Swiss Re AG

BATS-CHIXE:SRENz Stock Report

Market Cap: CHF 36.4b

Swiss Re Valuation

Is SRENz undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SRENz when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SRENz (CHF125.2) is trading below our estimate of fair value (CHF309.77)

Significantly Below Fair Value: SRENz is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SRENz?

Key metric: As SRENz is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SRENz. This is calculated by dividing SRENz's market cap by their current earnings.
What is SRENz's PE Ratio?
PE Ratio14x
EarningsUS$2.94b
Market CapUS$41.22b

Price to Earnings Ratio vs Peers

How does SRENz's PE Ratio compare to its peers?

The above table shows the PE ratio for SRENz vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21x
CRE Conduit Holdings
4.6x10.8%UK£768.4m
LGEN Legal & General Group
45.2x28.0%UK£12.7b
AV. Aviva
10.1x4.2%UK£12.9b
PRU Prudential
24x28.4%UK£16.6b
SRENZ Swiss Re
10.2x7.3%CHF 28.1b

Price-To-Earnings vs Peers: SRENz is good value based on its Price-To-Earnings Ratio (14x) compared to the peer average (21x).

Price to Earnings Ratio vs Industry

How does SRENz's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
No. of Companies12PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SRENz is expensive based on its Price-To-Earnings Ratio (14x) compared to the European Insurance industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is SRENz's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SRENz PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14x
Fair PE Ratio14.1x

Price-To-Earnings vs Fair Ratio: SRENz is good value based on its Price-To-Earnings Ratio (14x) compared to the estimated Fair Price-To-Earnings Ratio (14.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SRENz forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 125.20
CHF 100.97
-19.3%
11.4%CHF 122.72CHF 81.17n/a16
Nov ’25CHF 112.03
CHF 100.97
-9.9%
11.4%CHF 122.72CHF 81.17n/a16
Oct ’25CHF 115.40
CHF 100.97
-12.5%
11.4%CHF 122.72CHF 81.17n/a16
Sep ’25CHF 115.80
CHF 100.97
-12.8%
11.4%CHF 122.72CHF 81.17n/a16
Aug ’25CHF 108.85
CHF 100.97
-7.2%
11.4%CHF 122.72CHF 81.17n/a16
Jul ’25CHF 112.70
CHF 100.97
-10.4%
11.4%CHF 122.72CHF 81.17n/a16
Jun ’25CHF 114.55
CHF 100.97
-11.9%
11.4%CHF 122.72CHF 81.17n/a16
May ’25CHF 99.68
CHF 100.97
+1.3%
11.4%CHF 122.72CHF 81.17n/a16
Apr ’25CHF 116.05
CHF 100.97
-13.0%
11.4%CHF 122.72CHF 81.17n/a16
Mar ’25CHF 106.40
CHF 100.97
-5.1%
11.4%CHF 122.72CHF 81.17n/a16
Feb ’25CHF 97.62
CHF 100.97
+3.4%
11.4%CHF 122.72CHF 81.17n/a16
Jan ’25CHF 94.70
CHF 100.24
+5.8%
11.3%CHF 121.77CHF 80.54n/a16
Dec ’24CHF 98.34
CHF 101.90
+3.6%
12.3%CHF 125.86CHF 82.24n/a16
Nov ’24CHF 100.95
CHF 99.65
-1.3%
14.3%CHF 129.31CHF 77.58CHF 112.0316
Oct ’24CHF 94.48
CHF 99.63
+5.5%
13.8%CHF 131.28CHF 78.76CHF 115.4016
Sep ’24CHF 85.70
CHF 97.18
+13.4%
16.0%CHF 141.11CHF 75.60CHF 115.8016
Aug ’24CHF 91.02
CHF 95.45
+4.9%
12.6%CHF 117.01CHF 73.53CHF 108.8516
Jul ’24CHF 90.08
CHF 97.20
+7.9%
12.7%CHF 120.46CHF 75.70CHF 112.7017
Jun ’24CHF 92.64
CHF 97.12
+4.8%
13.0%CHF 121.81CHF 76.54CHF 114.5518
May ’24CHF 89.74
CHF 94.24
+5.0%
13.5%CHF 116.06CHF 72.45CHF 99.6817
Apr ’24CHF 93.82
CHF 94.61
+0.8%
13.4%CHF 118.47CHF 73.95CHF 116.0518
Mar ’24CHF 97.20
CHF 96.96
-0.3%
13.5%CHF 121.97CHF 76.14CHF 106.4018
Feb ’24CHF 93.90
CHF 89.55
-4.6%
11.9%CHF 111.93CHF 70.65CHF 97.6218
Jan ’24CHF 86.72
CHF 81.34
-6.2%
12.3%CHF 107.08CHF 62.94CHF 94.7018
Dec ’23CHF 84.76
CHF 80.28
-5.3%
11.7%CHF 108.23CHF 63.62CHF 98.3418
Nov ’23CHF 74.40
CHF 83.02
+11.6%
14.0%CHF 115.52CHF 54.30CHF 100.9519

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Swiss Re

CHF 28.1b

Provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide.

SRENZ

CHF 96.62

7D

2.0%

1Y

4.1%

FBD Holdings

€523.9m

Through its subsidiaries, engages in the underwriting of general insurance to farmers, private individuals, and business owners in Ireland.

FBH

€13.15

7D

0%

1Y

1.5%

Old Mutual

R55.8b

Provides financial services primarily in South Africa and rest of Africa.

OMUL

R0.56

7D

2.1%

1Y

6.5%